ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | ![](/images/29074/65842_A_2_6_rna_selected_60x60.jpg) | Group enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26292/55077_B_7_3_rna_selected_60x60.jpg) | Group enriched |
ALDH9A1 | Aldehyde dehydrogenase 9 family, member A1 | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images/6077/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10873/27712_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/47214/ihc_cell_selected_60x60.jpg) | ![](/images/47214/106718_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/41512/88685_B_8_7_rna_selected_60x60.jpg) | Expressed in all |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/19287/43914_B_9_2_rna_selected_60x60.jpg) | Group enriched |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5066/13292_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted membrane proteins
| | ![](/images/27435/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27435/62737_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
AMACR | Alpha-methylacyl-CoA racemase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | ![](/images/20912/if_selected_60x60.jpg) | | ![](/images/20912/48460_A_9_2_rna_selected_60x60.jpg) | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/32148/77451_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ANO4 | Anoctamin 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53412/128639_A_2_7_rna_selected_60x60.jpg) | Tissue enhanced |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2417/6119_B_9_2_rna_selected_60x60.jpg) | Group enriched |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/40199/88099_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
APH1A | APH1A gamma secretase subunit | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/37272/80629_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28971/148727_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/39319/if_selected_60x60.jpg) | | ![](/images/39319/82032_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55877/127848_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55877/127848_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/18885/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18885/42224_B_5_5_rna_selected_60x60.jpg) | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | ![](/images/1078/if_selected_60x60.jpg) | | ![](/images/1078/2858_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/1462/4467_A_1_5_rna_selected_60x60.jpg) | Expressed in all |
AQP1 | Aquaporin 1 (Colton blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1707/4765_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
AQP1 | Uncharacterized protein | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19206/44363_A_7_2_rna_selected_60x60.jpg) | Not detected |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42216/102949_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
AQP12B | Aquaporin 12B | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42216/102949_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/46834/ihc_cell_selected_60x60.jpg) | ![](/images/46834/147523_A_8_6_rna_selected_60x60.jpg) | Tissue enriched |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/14924/33951_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | ![](/images/14784/ihc_cell_selected_60x60.jpg) | ![](/images/14784/141532_B_8_3_rna_selected_60x60.jpg) | Group enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65008/145411_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15278/141832_A_1_5_rna_selected_60x60.jpg) | Tissue enriched |
ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited) | | | | ![](/images/23399/ihc_cell_selected_60x60.jpg) | ![](/images/23399/52492_A_2_5_rna_selected_60x60.jpg) | Expressed in all |
ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | Disease related genes
| | ![](/images/26078/if_selected_60x60.jpg) | | ![](/images/26078/55901_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36779/75092_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
ARHGEF10L | Rho guanine nucleotide exchange factor (GEF) 10-like | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28115/60625_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
ARHGEF28 | Rho guanine nucleotide exchange factor (GEF) 28 | | | ![](/images/37602/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/37602/80294_B_9_5_rna_selected_60x60.jpg) | Mixed |
ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | Predicted membrane proteins
| | | | ![](/images/15540/34874_B_7_5_rna_selected_60x60.jpg) | Expressed in all |
ARMC10 | Armadillo repeat containing 10 | Predicted membrane proteins
| | | ![](/images/11036/ihc_cell_selected_60x60.jpg) | ![](/images/11036/26770_B_2_3_rna_selected_60x60.jpg) | Expressed in all |
ARMCX1 | Armadillo repeat containing, X-linked 1 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5685/63762_B_9_7_rna_selected_60x60.jpg) | Expressed in all |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | ![](/images/549/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/549/1000_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11268/27966_B_8_2_rna_selected_60x60.jpg) | Group enriched |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/5468/ihc_cell_selected_60x60.jpg) | ![](/images/5468/15204_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
ASCC3 | Activating signal cointegrator 1 complex subunit 3 | Enzymes
| | | ![](/images/31608/ihc_cell_selected_60x60.jpg) | ![](/images/31609/65885_A_3_5_rna_selected_60x60.jpg) | Expressed in all |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15998/144741_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
ASL | Argininosuccinate lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/3696/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3696/9731_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | ![](/images/59303/133134_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
ASPHD1 | Aspartate beta-hydroxylase domain containing 1 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45175/99870_B_9_4_rna_selected_60x60.jpg) | Tissue enhanced |
ASPRV1 | Aspartic peptidase, retroviral-like 1 | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images/34809/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/34809/70519_B_7_5_rna_selected_60x60.jpg) | Tissue enriched |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images/17755/ihc_cell_selected_60x60.jpg) | ![](/images/17755/52926_A_4_7_rna_selected_60x60.jpg) | Tissue enriched |
ATG3 | Autophagy related 3 | | | | ![](/images_static/rna_center.gif) | ![](/images/40471/139668_B_9_7_rna_selected_60x60.jpg) | Expressed in all |
ATG4A | Autophagy related 4A, cysteine peptidase | Enzymes
| | ![](/images/36374/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36374/75172_B_8_3_rna_selected_60x60.jpg) | Expressed in all |